title: Echis time, under-carboxylated prothrombin and vitamin K status in intensive care patients.
abstract: Vitamin K deficiency is a known cause of coagulopathy in hospitalized patients, but the extent of the problem has not been well assessed. This noninterventional, prospective observational study of 35 adults was undertaken in the intensive care unit (ICU) and examined the incidence of and the methods for diagnosing vitamin K deficiency. Measurements of prothrombin time, Echis time and plasma concentrations of under-carboxylated prothrombin (proteins induced in vitamin K absence or antagonism, PIVKA-II), vitamin K1 and ferritin were made during the 48 h after admission to the unit and repeated if coagulopathy developed later. Plasma vitamin K1 was low in 15 admissions (43%), in 11 cases of patients with coagulopathy and in four cases without coagulopathy. PIVKA-II was present in 12 cases (34%), of whom four had low vitamin K1 levels. All of the eight patients with raised PIVKA-II but normal vitamin K concentration were hyperferritinaemic. We conclude that low plasma vitamin K levels, suggestive of low tissue stores, are common in intensive care patients with or without coagulopathy. As 34% of patients had a raised PIVKA-II, this suggests that vitamin K stores may be insufficient to maintain full gamma-carboxylation of prothrombin and emphasize the need to anticipate vitamin K deficiency in the ICU setting by appropriate supplementation.
authors.affiliation: Department of Haematology, Southampton General Hospital, London, UK. kcb07@dial.pipex.com
authors.forename: D
authors.initials: D
authors.lastname: O'Shaughnessy
authors.forename: C
authors.initials: C
authors.lastname: Allen
authors.forename: T
authors.initials: T
authors.lastname: Woodcock
authors.forename: K
authors.initials: K
authors.lastname: Pearce
authors.forename: J
authors.initials: J
authors.lastname: Harvey
authors.forename: M
authors.initials: M
authors.lastname: Shearer
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D015415:Biomarkers / Q000032:analysis*; D001777:Blood Coagulation / Q000187:drug effects; D001778:Blood Coagulation Disorders / Q000097:blood / Q000453:epidemiology; D001780:Blood Coagulation Tests; D005260:Female; D005293:Ferritins / Q000032:analysis / Q000097:blood; D006801:Humans; D007362:Intensive Care Units / Q000706:statistics & numerical data; D019934:International Normalized Ratio; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D011498:Protein Precursors / Q000032:analysis*; D011499:Protein Processing, Post-Translational; D011516:Prothrombin / Q000032:analysis*; D014757:Viper Venoms / Q000494:pharmacology; D010837:Vitamin K 1 / Q000097:blood*; D014813:Vitamin K Deficiency / Q000097:blood / Q000175:diagnosis / Q000453:epidemiology*
chemical_list: D015415:Biomarkers; D011498:Protein Precursors; D014757:Viper Venoms; C008208:acarboxyprothrombin; D010837:Vitamin K 1; D011516:Prothrombin; D005293:Ferritins